| Literature DB >> 27123818 |
Mitja Rak1,2, Martina KavčIč2, Rihard Trebše3, Andrej CőR1,3.
Abstract
Background and purpose - The correct diagnosis of prosthetic joint infection (PJI) can be difficult because bacteria form a biofilm on the surface of the implant. The sensitivity of culture from sonication fluid is better than that from periprosthetic tissue, but no comparison studies using molecular methods on a large scale have been performed. We assessed whether periprosthetic tissue or sonication fluid should be used for molecular analysis. Patients and methods - Implant and tissue samples were retrieved from 87 patients who underwent revision operation of total knee or total hip arthroplasty. Both sample types were analyzed using broad-range (BR-) PCR targeting the 16S rRNA gene. The results were evaluated based on the definition of periprosthetic joint infection from the Workgroup of the Musculoskeletal Infection Society. Results - PJI was diagnosed in 29 patients, whereas aseptic failure was diagnosed in 58 patients. Analysis of sonication fluid using BR-PCR detected bacteria in 27 patients, whereas analysis of periprosthetic tissue by BR-PCR detected bacteria in 22 patients. In 6 of 7 patients in whom BR-PCR analysis of periprosthetic tissue was negative, low-virulence bacteria were present. The sensitivity and specificity values for periprosthetic tissue were 76% and 93%, respectively, and the sensitivity and specificity values for sonication fluid were 95% and 97%. Interpretation - Our results suggest that sonication fluid may be a more appropriate sample than periprosthetic tissue for BR-PCR analysis in patients with PJI. However, further investigation is required to improve detection of bacteria in patients with so-called aseptic failure.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27123818 PMCID: PMC4967274 DOI: 10.3109/17453674.2016.1165558
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Demographic and clinical data
| Prosthetic joint infection | Aseptic failure | |
|---|---|---|
| No. of patients | 29 | 58 |
| Age (range) | 70 (54–88) | 70 (29–86) |
| No. of females | 12 | 44 |
| No. of males | 17 | 14 |
| Joint | ||
| Knee | 12 | 29 |
| Hip | 17 | 29 |
| First revision | 20 | 39 |
| Repeated revision | 9 | 19 |
| Median no. of samples retrieved (range) | 6 (5–8) | 6 (5–10) |
| Time of implant failure | ||
| Early (0–3 months] | 6 | 0 |
| Delayed (3–24 months) | 6 | 19 |
| Late (< 24 months) | 17 | 39 |
| Median time of prosthesis in vivo, months (range) | 36 (0–213) | 45 (5–270) |
| Median time of transport, h (range) | 1:30 (0:32–18:40) | 1:49 (0:40–3:29) |
| Median ESR (range), mm/h | 80 (0–81) | 3 (0–30) |
| Median CRP (range), mg/L | 62 (15–170) | 9 (0–165) |
| Histology: no. of patients with >5 PMN/HPF | 16 | 4 |
| Antimicrobial therapy before operation | 8 | 3 |
ESR: erythrocyte sedimentation rate; CRP: C-reactive protein;
PMN: polymorphonuclear neutrophils; HPF: high-power field.
Identified bacteria with molecular methods in periprosthetic tissue and sonicate fluid among the patients with PJI
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 86 | 25 | M | K | + | − | + | + | + | + | − | 2 | ||
| 2 | 79 | 39 | M | H | − | − | + | − | − | + | + | 6 | ||
| 3 | 60 | 11 | F | H | + | − | − | − | + | − | − | / | 0 | |
| 5 | ||||||||||||||
| 5 | ||||||||||||||
| 4 | 83 | 66 | M | H | + | − | − | − | − | − | + | 4 | ||
| 7 | 87 | 89 | F | K | + | − | − | − | + | + | + | 6 | ||
| 12 | 73 | 29 | M | H | + | − | − | − | + | + | − | 2 | ||
| 13 | 65 | 1 | M | K | − | − | − | − | − | + | + | 5 | ||
| 15 | 78 | 2 | M | H | + | + | − | − | − | − | + | / | 0 | |
| 6 | ||||||||||||||
| 18 | 70 | 64 | F | H | + | − | − | − | + | + | + | 1 | ||
| 21 | 70 | 1 | M | H | + | − | + | + | − | − | − | / | 0 | |
| 22 | 70 | 100 | M | H | + | − | + | + | + | − | − | 3 | ||
| 23 | 59 | 80 | M | H | + | − | − | − | + | − | − | / | 0 | |
| 4 | ||||||||||||||
| 2 | ||||||||||||||
| 24 | 66 | 12 | F | K | + | + | + | + | + | − | − | 2 | ||
| 29 | 73 | 189 | F | H | − | − | + | + | + | + | − | 6 | ||
| 35 | 66 | 152 | F | H | + | − | + | + | + | + | − | 6 | ||
| 37 | 61 | 0 | M | H | + | − | − | − | − | − | − | / | 0 | |
| 40 | 74 | 46 | M | K | + | − | − | − | − | + | − | 2 | ||
| 44 | 83 | 36 | M | H | + | − | − | − | − | + | − | 3 | ||
| 47 | 54 | 60 | F | H | − | − | − | − | − | − | − | / | / | |
| 50 | 56 | 6 | F | K | + | − | + | + | + | − | + | 2 | ||
| 51 | 69 | 1 | M | K | + | − | − | − | + | − | − | 3 | / | |
| 52 | 69 | 118 | F | K | + | − | − | − | + | − | + | 4 | ||
| 53 | 78 | 51 | M | H | − | − | + | − | − | + | − | 3 | ||
| 64 | 74 | 104 | M | K | + | − | − | − | + | + | + | 4 | ||
| 67 | 71 | 8 | M | H | + | − | − | − | − | − | − | 3 | ||
| 68 | 88 | 213 | F | K | + | − | − | − | − | + | − | 3 | ||
| 73 | 63 | 23 | F | K | + | − | − | − | + | − | − | / | 0 | |
| 77 | 74 | 2 | F | K | + | − | − | − | − | − | − | 3 | ||
| 82 | 65 | 12 | M | H | − | − | + | + | + | − | − | 3 | ||
The patient was diagnosed with PJI based on culture results of periprosthetic tissue.
A Patient number
B Age of patient
C Time of implant in vivo, months.
D Sex
E Joint: H – hip, K – knee.
F C-reactive protein >10 mg/L.
G Erythrocyte sedimentation rate >30 mm/h.
H White blood cell count in synovial fluid >1.7 × 109/L.
I Polymorphonuclear neutrophil (PMN) count in synovial fluid >65%.
J Histology: > 5 polymorphonuclear neutrophils/high-power field.
K Purulence
L Fistula/sinus
M Identified bacteria in periprosthetic tissue.
N Number of positive samples with the same bacterial species identified with molecular methods.
O Identified bacteria by sonication.
Identified bacteria with molecular and culture methods in periprosthetic tissue and sonicate fluid 2 among the patients with AF
| A | B | C | D | E | F | G | H | I | J | K | L | M | L | N |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identified bacteria with molecular methods were considered insignificant due to criteria | ||||||||||||||
| 10 | 66 | 13 | F | K | − | − | + | − | < 5 | / | 0 | 1 | / | |
| 14 | 62 | 16 | M | K | − | − | − | − | < 5 | 1 | ||||
| 1 | 1 | / | ||||||||||||
| 1 | 1 | |||||||||||||
| 1 | ||||||||||||||
| 31 | 82 | 116 | F | H | − | − | − | − | 0 | / | 0 | 1 | ||
| 36 | 81 | 60 | F | K | − | − | − | − | < 5 | / | 0 | 1 | / | |
| 39 | 83 | 58 | F | H | − | − | − | − | > 25 | / | 0 | 1 | / | |
| 79 | 74 | 9 | M | H | − | − | − | − | 0 | 1 | 1 | / | ||
| Bacteria identified with molecular methods, considered significant due to criteria | ||||||||||||||
| 16 | 75 | 17 | F | K | + | − | − | − | < 5 | / | 0 | 2 | / | |
| 17 | 43 | 30 | M | H | − | − | − | − | < 5 | / | 0 | 5 | / | |
| 63 | 54 | 21 | F | K | − | − | − | − | 0 | 1 | ||||
| 1 | 2 | / | ||||||||||||
| 1 | ||||||||||||||
| Identified bacteria with molecular methods were considered significant due to patient history and culture results | ||||||||||||||
| 8 | 62 | 59 | F | K | + | − | − | − | > 25 | / | 0 | / | 0 | |
| 9 | 73 | 28 | M | K | − | − | − | − | < 5 | / | 0 | / | 0 | |
| 75 | 75 | 20 | F | K | + | − | − | − | 0 | / | 0 | / | 0 | |
| 87 | 55 | 17 | F | K | + | − | − | − | < 5 | 1 | 3 | |||
A Patient number
B Age of patient
C Time of implant in vivo, months.
D Sex
E Joint: H – hip, K – knee.
F C-reactive protein >10 mg/L.
G Erythrocyte sedimentation rate >30 mm/h.
H White blood cell count in synovial fluid >1.7 × 109/L.
I Polymorphonuclear neutrophil (PMN) count in synovial fluid >65%.
J Polymorphonuclear neutrophils/high-power field.
K Identified bacteria by culture from periprosthetic tissue
L Number of positive samples with the same bacterial species
M Identified bacteria by molecular methods from periprosthetic tissue
N Identified bacteria by sonication
Criteria for interpretation of BR-PCR results. Bacterium was considered significant if it was identified in at least 2 samples of periprosthetic tissue.
Patient was on antibiotic therapy prior to revision operation. In Case 8 S. aureus was isolated from synovial fluid.
Statistical parameters for analysis of periprosthetic tissue and sonication fluid by molecular methods
| Method | TP | FP | TN | FN | Sensitivity | Specificity | PPV | NPV |
|---|---|---|---|---|---|---|---|---|
| BR-PCR PT >2 | 22 | 4 | 54 | 7 | 76 (56–89) | 93 (83–98) | 85 (64–95) | 89 (77–95) |
| BR-PCR SF | 27 | 4 | 54 | 2 | 93 (76–99) | 93 (83–98) | 87 (69–96) | 96 (87–99) |
TP: true positive; FP: false positive; TN: true negative; FN: false negative; SE: sensitivity; SP: specifi city; PPV: positive predictive value; NPV: negative predictive value; PT: periprosthetic tissue; SF; sonication fluid.
Bacteria were considered significant if the same species was present in at least 2 samples of periprosthetic tissue; 95% confidence intervals are given in parentheses. Clinical Calculator 1 (Lowry 2001) was used for calculation of sensitivity, specificity, positive and negative predictive value, and confidence intervals.